Norwood EyeCare reception provides a 'taste of Australia'

April 18 - Washington, DC - Attendees of the American Society of Cataract and Refractive Surgery meeting enjoyed a festive evening of Australian wines, hors d'oeuvres, and music at a Sunday evening reception sponsored by Norwood EyeCare, a subsidiary of Norwood Abbey Ltd. The Australian-based company has much to celebrate.

Norwood EyeCare announced results of three clinical studies this week at the ASCRS meeting. All three studies employed Norwood EyeCare's Epikeratome for Epi-LASIK. The study results-including the evaluation of visual acuity results, pain, haze, and corneal sensitivity-suggest that Epi-LASIK with the Norwood EyeCare Epikeratome is a safe and effective modality for the treatment of low and moderate myopia, based on a 1-year follow-up.

The company also recently entered into an exclusive partnership for the German and Swiss markets with Schwind eye-tech-solutions GmbH and Co.KG, supplier of laser and surgical equipment used in laser vision-correction surgery.

In addition, Norwood EyeCare announced that as part of the global expansion of its ophthalmic product line it has appointed distributors for its Centurion SES System with EpiEdge (disposable separator) in Japan, Thailand, and Russia.

Representatives from the company-including Mike Crocetta, president of Norwood EyeCare, and Lamar Chandler, vice president/marketing for Norwood EyeCare-were on hand to welcome attendees. Special guests included Ioannis Pallikaris, MD, PhD; Richard Yee, MD; Michael C. Knorz, MD; Warren D. Cross, MD; R. Gale Martin, MD; Marguerite McDonald, MD, FACS; Daniel Durrie, MD; and Vikentia Katsanevaki, MD, PhD.